Alpha Crest Capital Management LLC Axonics, Inc. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $5,738 - $7,733	-99 Reduced 0.68%	14,390 $1.01 Million
Q2 2022 Aug 11, 2022	BUY	$39.5 - $64.42 $446,113 - $727,559	11,294 Added 353.49%	14,489 $821,000
Q1 2022 May 12, 2022	BUY	$43.74 - $62.76 $139,749 - $200,518	3,195 New	3,195 $200,000
Q4 2021 Feb 09, 2022	SELL	$50.01 - $73.35 $466,743 - $684,575	-9,333 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$59.21 - $78.66 $552,606 - $734,133	9,333 New	9,333 $607,000
Q1 2021 May 13, 2021	SELL	$49.14 - $59.89 $624,078 - $760,603	-12,700 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $113,913 - $139,050	2,700 Added 27.0%	12,700 $634,000
Q3 2020 Nov 12, 2020	BUY	$35.33 - $51.04 $353,300 - $510,400	10,000 New	10,000 $510,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.